Cross-presentation of tumor antigens at the immune synapse between antigen-presenting dendritic cells and T lymphocytes can potentially activate an adaptive antitumor immune response that is mediated by CD4+ T-helper cells (TH1) and CD8+ cytotoxic effector cells, and sustained by tumor-reactive central memory T cells1. The gene discussed is CD8A; the disease is neoplasm.